Kimberly Page
Nurse Practitioner · Atlanta, GANPI 1740660984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$625
- Incyte Corporation$578
- E.r. Squibb & Sons, L.L.C.$328
- Legend Biotech USA Inc.$238
- Astellas Pharma US Inc$198
- Gilead$165
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,93698%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 27 | $625 |
| Incyte Corporation | 20 | $578 |
| E.r. Squibb & Sons, L.L.C. | 3 | $328 |
| Legend Biotech USA Inc. | 5 | $238 |
| Astellas Pharma US Inc | 9 | $198 |
| Gilead | 5 | $165 |
| Sanofi | 2 | $144 |
| Amgen | 7 | $132 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $130 |
| AbbVie | 5 | $115 |
| Karyopharm Therapeutics Inc. | 6 | $112 |
| Johnson & Johnson | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| GSK | 5 | $99 |
| Seagen Inc. | 6 | $91 |
| Sobi, Inc | 5 | $79 |
| Jazz Pharmaceuticals Inc. | 4 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Syndax Pharmaceuticals, Inc. | 3 | $65 |
| Merck | 2 | $61 |
| ADC Therapeutics America, Inc. | 3 | $61 |
| Novartis | 2 | $59 |
| Genentech USA, Inc. | 3 | $58 |
| Blueprint Medicines Corporation | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Morphosys, US Inc. | 3 | $43 |
| Servier Pharmaceuticals LLC | 2 | $34 |
| Acrotech Biopharma Inc. | 2 | $34 |
| Boston Scientific | 1 | $27 |
| Coherus Oncology, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Beigene USA, Inc. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,035 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone | 13 | $10,688 |
| Acyclovir | 36 | $635 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $72 |
| Amlodipine Besylate | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Atlanta
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Casey MillerAtlanta$41K
- Kathryn InanAtlanta$17K
- Colby DoepelAtlanta$16K
- Mark HebertAtlanta$15K
- Ashley BlackmonAtlanta$13K
- Alexia CovingtonAtlanta$13K
- Marissa TorresAtlanta$12K
- Hayley TurnerAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.